infections of the nervous system - bacterial infections
TRANSCRIPT
Infections of the Nervous System -
Bacterial Infections
Acute Bacterial Meningitis
Definition: Acute purulent infection within the
subarachnoid space Pia-arachnoid Cerebrospinal fluid
Brain parenchyma frequently involved Meningoencephalitis
Epidemiology
Most common of suppurative CNS infection Incidence: 3-5/100 000
Highest in the first month of life Nearly 75% occur in children under 15
Vaccination led to: Dramatic decline in the incidence of Haemophilus
influenzae meningitis Smaller decline in Neisseria meningitidis
meningitis
Community-Acquired Meningitis:Etiology
Streptococcus pneumonia-50% N. Meningitidis-25% Group B streptococci-15% Listeria monocystogenes-10% H. Influenzae- less than 10%
Pathophysiology
Colonization of nasopharynx Bacteremia and infection of choroid plexus Invasion of the subarachnoid space and
multiplication in CSF Induction of inflammatory reaction:
Release of inflammatory cytokines Upregulation of adhesion molecules Granulocyte penetration into CSF and further
release of inflammatory mediators
Pathophysiology
Increased vascular permeability causes vasogenic edema
Toxins released by bacteria and granulocytes lead to cellular damage and loss of cellular homeostasis and worsen cerebral edema
Obstruction of CSF leads to hydrocephalus Vasculitis and Thrombosis leads to infarction Cerebral herniation
PUS IN SUBARACHNOID SPACE
VIRCHOW-ROBIN SPACE
Pathophysiology
Parameningeal structures: Ears, paranasal sinuses Osteomyelitic foci in the skull Congenital sinus tracts Penetrating cranial injuries
Iatrogenic source : Brain or spine surgery Ventriculoperitoneal shunt Rarely post- lumbar puncture).
Undetermined
Clinical Presentation
Onset: Acute fulminant-few hours Subacute-over several days
Classic clinical triad: fever,headache and nuchal rigidity (stiff neck)-each more than 90%
Alteration in mental status:lethargy-coma-more than 75%
Nausea,vomiting and photophobia
Clinical Presentation
Seizures: 20-40% Focal or generalized Focal seizures:
Infarction Cortical venous thrombosis with hemorrhage Focal edema
Generalized: Anoxia, hyponatremia, drugs Petechial lesions in meningococcal
meningitis.
Diagnosis
When bacterial meningitis is suspected: Obtain blood culture Initiate empirical antimicrobial therapy
The diagnosis is made by examination of CSF
Neuroimaging is needed before LP: H/O head injury, Papilledema, altered level of
consciousness and focal neurological signs
CSF Abnormalities In Bacterial Meningitis
Opening pressure More than 180 mm H2O
White blood cells 1000-100 000 cells/mm3
Glucose <2.2 mmol/l
CSF/serum glucose
<0.4
Protein 100-500mg/dl
Gram stain Positive in >60%
CSF Abnormalities In Bacterial Meningitis
Culture Positive in >80%
Latex agglutination
May be positive in S.Pneumoniae,N.meningitidis,H.influenzae-b ,E.coli and G-B streptococci
Limulus Lysate Detects gram negative meningitis endotoxin
PCR for bacterial DNA
Research test
Diagnosis
MRI: may demonstrate: Cerebral edema Ischemia Meningeal enhacement with gadolinium
Biopsy of petechial skin lesions: Gram stain may reveal meningococci
Differential Diagnosis
Headache, fever, altered consciousness, focal neurological signs and focal or generalized seizures
Periodic lateralized epileptiform discharges (PLEDS)
Lymphocytic pleocytosis with normal sugar Orbitofrontal or medial temporal lobes
changes in MRI.
MENINGOENCEPHALITIS
HERPES SIMPLEX VIRUS ENCEPHALITIS
Differential Diagnosis
Rocky Mountain spotted fever Subdural and epidural empyema, brain
abscess Suharachnoid hemorrhage Chemical meningitis: Rupture of tumor Carcinomatous or lymphomatous meningitis SLE, Sarcoid, Behcet disease
Treatment:Empirical Antibiotics
Preterm infant to infant<1 month
Ampicillin+cefotaxime
Infant 1-3 months Ampicillin+cefotaxime or cefotrixone
Immunocompetent children>3m+adult<55
Cefotaxime or cefotriaxone+vancomycin
Adults>55+alcoholism+debilitating illness
Cefetaxime or ceftriaxone+ampic+vanc
Hosp-acquired, posttrauma, neurosurg
Ampicillin+Vancomycin+ceftazidime
Antibiotics Based on Pathogen
N.meningitides-PEN-S Penicillin G or Ampicillin
N.meningitides-PEN-R Ceftriaxone/ cefotaxime
S.pneumonia-PEN-S Penicillin G
S.pneuomonia-PEN-R Cefotrixone+vancomycin
Gram-negative bacilli Ceftriaxone/ cefotaxime
Psedomonas aeruginosa Ceftazidime
Staphylococci-M-S/R Nafcillin/Vancomycin
Antibiotics Based on Pathogen And Adjunctive Therapy
Listeria monocystogenesis Ampicillin+gentamycin
Haemophilus Influenzae Ceftriaxone/ cefotaxime
Streptococcus agalactiae Penicillin G+Ampicillin
Adjunctive therapy Dexamethasone 10 mg 15-20 min before 1 dose
Increased ICP Elevate head,mannitol hyperventilation
Tuberculosis Meningitis
Clinical Features. Subacute-chronic course with:
low-grade fever, headache, and intermittent nausea and vomiting
followed by more severe headache, neck stiffness, altered sensorium
cranial nerve palsies (usually III, but also II, VII, and VIII) Untreated disease progresses with:
more pronounced meningeal signs, seizures focal neurological deficits, including hemiparesis, increasing drowsiness, and signs of increased ICP
Basal Meningitis
Vasculitis
Diagnosis
Identifying tubercle bacilli on: CSF acid-fast bacilli (AFB) smear or culture establishes
the diagnosis. AFB smear is diagnostic in only 10-30% of cases CSF culture results are positive for M. tuberculosis in 45-
70% of patients but may take 6-8 weeks to become positive.
Because a negative CSF AFB smear result does not rule out TB meningitis and the culture may not yield organisms for weeks, empiric anti-TB therapy can be started as early as possible on the basis of clinical suspicion
Diagnosis: CSF examination
Demonstrates normal or elevated opening pressure Elevated protein (1-5g/L) Low glucose (1.7-2.5 mmol/L) Pleocytosis (averaging 200-400 WBC/mm³ with
lymphocytic predominance). However, patients with miliary TB or CNS
tuberculomas may have a normal CSF initially.
Diagnosis
Investigations should include: general examination for lymphadenopathy and
hepatosplenomegaly Retinal examination for choroidal tubercles chest radiography for lung infection tuberculin test Cranial CT or MRI showing basal meningeal and
sylvian exudates and enhancement with hydrocephalus suggests the diagnosis
Tuberculomas Single or multiple brain or spinal cord lesions Present with signs and symptoms of space-occupying lesions. On CT or MRI scan:
the lesions may be of low or high intensity with ring enhancement Miliary disease is characterized by multiple small (1-2 mm)
lesions. Open or stereotactic biopsy may be necessary if definitive
diagnosis of TB cannot be made at an extraneural site. In regions in which TB is prevalent, the decision to initiate anti-
TB therapy may be made without histological confirmation.
Tuberculomas
Tuberculomas
Spinal Tuberculosis
The most common site of involvement by TB of the spine is in midthorax region.
Back pain is the chief complaint, and paraspinal muscle spasms or kyphotic deformity of the spine (from collapse of vertebra, a gibbus) may be found on examination.
Plain films show: decreased bone density and joint space destruction in long-
standing disease, but may be normal in early disease. Radionuclide bone scanning improves detection of spinal TB, but the best modality is MRI, which simultaneously visualizes the
spinal cord.
Spinal Tuberculosis Progressive paraparesis requires urgent surgical
intervention. Surgery also may be indicated:
for biopsy if the diagnosis is in doubt or to obtain cultures for sensitivities.
The differential diagnosis of vertebral bacterial diseases includes: infections with staphylococci, streptococci and typhoid and other gram-negative bacilli paratyphoid disease brucellosis.
TBM: Management
Isoniazid (INH) 5-10mg/kg (max 300 mg) PO
add pyridoxine,Hepatitis (1-2%), neuropathy (5%), seizures
Rifampin Child 15mg/kg PO, Adult 10mg/kg PO
Hepatitis (1-2%), hypersensitivity
Pyrazinamide 25mg/kg (max 2.5 g/day) PO
Arthralgia (5%), hepatitis (1-5%), hyperuricemia, gout, rash
TBM: Management
Streptomycin Child 30 IM Adult 15mg/kg (max 1 g/day) IM
Hearing loss, vestibular imbalance (1-5%)
Ethambutol 15-25mg/kg (max 2.5 g/day) PO
Optic neuritis
Corticosteroids Severely ill patients
Impending spinal block
Differential diagnosis Untreated or partially treated bacterial meningitis, Other granulomatous meningitides (spirochetes, Brucella, Most fungi Parasites such as Amoeba, Toxoplasma, and trypanosomes), A subacute or chronic granulomatous conditions:
CNS sarcoid lupus Behçet's, granulomatous angiitis
Lymphomatous or carcinomatous meningitis
TBM:MRI
Brucellosis
A zoonosis caused by Brucella species: B. melitensis B. abortus B. suis) Normally a disease of domestic and wild animals Brucellosis is transmitted to humans by ingestion of infected
unpasteurized milk, by aerosol spread, or by contact with infected animals or animal products.
The disease exists worldwide, but is especially prevalent in Mediterranean regions the Middle East, the Indian subcontinent Latin America.
Brucellosis:Acute Febrile Illness
Common symptoms: Chilly sensation, sweats, fever, generalized
malaise Bodyaches in 60% Headache in 50%
Physical signs: Lymphadenopathy, splenomegaly,hepatomegaly Spinal tenderness
Clinical Presentation
Subacute/chronic stages in 15-20% of patients with localized of Bones Joints Lungs Kidneys Liver Lymph nodes and other organs
Nervous Involvement
Is not common Meningitis with cranial nerve palsies Meningoencephalitis Meningomyelitis Optic neuritis Peripheral neuritis Brain Abscess
Cerebrospinal Fluid
Increased opening pressure Lymphocytic pleocytosis: few-several
hundred cells Protein is moderately or greatly increased Sugar content is decreased Elevated immunoglobulins Often contain Brucella agglutinating
antibodies
Neurobrucellosis:Pathology
Subacute meningitis with perivascular infiltrations
Thickening of the vessels in the brain and spinal cord
Degenerative changes in the white and grey matter
Organisms cultured from CSF in few patients
Neurobrucellosis: Diagnosis
History Culture of organism from blood or CSF Positive Brucella agglutination or ELISA test
results with high titers of antibody in blood and CSF
Neurobrucellosis:Treatment
Three-drug therapy with: doxycycline+ an aminoglycoside+ rifampin
for at least 12 weeks. Children under 8 years of age are treated
with trimethoprim/sulfamethoxazole + aminoglycoside +refambin
Adjunctive corticosteroid therapy has been used for concurrent vasculitic or demyelinating disease
LYME DISEASE
Caused by a tick-born spirochaete-Borrelia burgdorferi-Endemic in Europe ands USA
Deer is the natural host for the adult tick The organism can be cultured from brain,
CSF,blood and Skin Pathology:
Meningeal inflammation Perivascular inflammatory cell infiltrate Focal demyelination
LYME DISEASE: Three Stage Course
Initial skin reaction-Erythema chronicum migrans in 60-80% within 3-4 weeks of expoture Myalgia Malaise fever Headache
Erythema chronicum migrans
Neurological Features
Occur in 10-15% of patients Cranial nerve palsies, mainly fifth and
seventh Radiculopathy or myeloradiculopathy Meningitis:CSF lymphocytosis and mild
elevation of protein and oligoclonal bands Encephalitis
Arthritis
Single or multiple joints Remitting and relapsing Diagnosis:
Elevated serum and CSF antibody to B.burgdorferi
Treatment: Severe: IV ceftriaxone Mild: Facial weakness-oral amoxicillin or
doxicyclin
Brain Abscess
Focal infection of the brain Mode of infection:
Infected cotaguous site: ear or sinus Hematogenous: from lungs
Symptoms: Focal signs,fever, headache, neck stiffness Elevated white cell count Diagnosis: MRI or CT scan
Brain Abscess
LP Iis containdicated Treatment:
Surgery Antibiotics
MItronidazole Ceftrixone